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Book Reviews
Catalog of Chromosome Aberrations in Cancer
Fifth Edition. Edited by Felix Mitelman. Wiley-Liss, Inc.:
New York. 1994, 4252 pp. £345.00. ISBN 047111183X.
Mitelman's catalogue is the only comprehensive reference
book of aberrant karyotypes in malignancy. The fifth
edition provides us with a staggering collection of
karyotypes from more than 22 000 individual neoplasms.
Drawn from 5224 references this latest edition reflects the
explosive growth in this field of research in' recent years.
Twelve years ago when Mitelman first identified the need
for such a catalogue the total number of karyotypes was
little more than 3000.
The catalogue comes in two volumes with chromosomes
1-12 and 13-22XY. Cases are classified first by chromo-
some and are entered under each abnormal chromosome in
the karyotype. It follows that any one case may appear under
several different chromosomes. The relative contribution of
solid tumour entries in this edition is 27% of cases compared
with 12% of entries in 1983. Clearly solid tumours are still
underrepresented in terms of their natural incidence but the
extreme complexity of many solid tumour karyotypes (the
record being held by a fibrosarcoma karyotype with no less
than 1051 characters) means their contribution to the
catalogue is substantial. Apart from bringing the number of
cases up to date this edition describes every karyotype
according to the most recent terminology, namely the
International System for Cytogenetic Nomenclature 1991.
The number of karyotypes investigated by molecular
techniques for genetic rearrangements or fusion genes and
described at the end of each chromosomal section has also
been updated.
Entries are subclassified by types of disease which include
46 haematological disorders, 35 malignant lymphomas and 98
benign and malignant solid tumours. Drawn from all over the
world, cases are taken from publications in more than 30
scientific journals. The geographical distribution of cases
reflects national or local interest in cytogenetics. In this
context, it is of interest that the largest contributing continent
is Europe and that the UK features fourth largest among
contributing countries or states.
Over the past 25 years many clinically important
chromosomal subgroups have been detected within morpho-
logically identical types of malignant disorder. Their
identification has resulted from the drawing together of
large numbers of individual cases. Nevertheless, the numbers
of aberrant karyotypes found in any series of any one tumour
type are many and various. The overwhelming impression is
one of diversity. New subgroups only emerge when newly
described cases can be checked against previously published
cases and here the catalogue is indispensible. Chromosomal
aberrations in human cancer highlight regions of the genome
which have the potential to initiate mutagenesis. These are
frequently the reference points for molecular investigations of
neoplastic genetic change. The catalogue provides a useful
summary of chromosomal change which has already been
investigated in this way.
In short, the catalogue is a well-designed and user-friendly
collection of the complex chromosomal abnormalities that
occur in malignant conditions. A comprehensive bibliography
ensures that full details of published cases are readily
accessible. Any research group that has been working on
cytogenetic or molecular changes in malignancy will already
have an earlier edition of the catalogue and will want to
update it. Those entering the field would be well advised to
equip themselves with a copy of the Fifth edition forthwith.
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